Clinical Trial Update: Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 trial of an adenoviral vector therapy as monotherapy or with chemotherapy for recurrent/metastatic breast cancer was terminated; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adenoviral vector therapy (investigational)

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Breast Cancer Nos Metastatic Recurrent | Phase 2 | Status: TERMINATED | Results posted: 2025-08-28